I will be introducing legislation that will require insurance coverage for ovarian cancer screenings.

Ovarian cancer is often called the “silent killer” because it can develop without symptoms, which means a diagnosis is often discovered at an advanced stage. This was the case with one of my brave constituents. Her husband has been working hard to bring this issue to the attention of lawmakers.

The American Cancer Society estimates that 20,890 women will receive a new diagnosis of ovarian cancer in 2025, and 12,730 women will die from ovarian cancer. Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system.
Cancer screenings are proven tools that can detect cancer at an early stage and before symptoms appear. This early detection leads to better treatment plans and better odds of a patent becoming cancer-free. A simple blood screening test called CA-125, which measures protein in the blood, can detect potential signs of ovarian cancer. Elevated protein levels are found in about 80% of women with later-stage ovarian cancer and 50% of women with early-stage ovarian cancer. There are other screenings that can detect signs of ovarian cancer, such as a transvaginal ultrasound or pelvic exam. Unfortunately, these screenings are not universally covered by private health insurance.

My legislation would require insurers to cover ovarian cancer screening tests for women over age 40. This policy will be modeled after bills overwhelmingly passed by the General Assembly with respect to breast cancer and colon cancer. I believe we should have the same form of insurance benefit for woman to test against this silent killer.

I ask that you join me as we continue this fight against cancer and give all those at risk a fighting chance.